← Open Payments lookup

AMY AGENA: Open Payments

NPI 1114195526 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$922 in 54 payments from 12 companies in 2025. Trend: 2023 $695 · 2024 $491 · 2025 $922

Food & beverage: $922
CompanyPaymentsAmount
ABBVIE INC.18$328
Novo Nordisk Inc19$257
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$83
Boston Scientific Corporation1$48
AstraZeneca Pharmaceuticals LP3$43
Janssen Pharmaceuticals, Inc2$40
Boehringer Ingelheim Pharmaceuticals, Inc.2$31
Abbott Laboratories1$24
Biogen, Inc.1$22
Esperion Therapeutics, Inc.1$18

Products named: VRAYLAR, Wegovy, Ozempic, CAPLYTA, QULIPTA, General - Pain Management, UBRELVY, Rybelsus.

Industry payments across NE — which companies pay providers there.